Pigment dispersion syndrome
MONDO:0010896Pigment-dispersion syndrome is an eye disorder that occurs when pigment granules that normally adhere to the back of the iris (the colored part of the eye) flake off into the clear fluid produced by the eye (aqueous humor). These pigment granules may flow towards the drainage canals of the eye, slowly clogging them and raising the pressure within the eye (intraocular pressure or IOP). This rise in eye pressure can cause damage to the optic nerve (the nerve in the back of the eye that carries visual images to the brain). If the optic nerve becomes damaged, pigment-dispersion syndrome becomes pigmentary glaucoma. This happens in about 30% of cases. Pigment-dispersion syndrome commonly presents between the second and fourth decades, which is earlier than other types of glaucoma. While men and women are affected in equal numbers, men develop pigmentary glaucoma up to 3 times more often than women. Myopia (nearsightedness) appears to be an important risk factor in the development of pigment-dispersion syndrome and is present in up to 80% of affected individuals. The condition may be sporadic or follow an autosomal dominant pattern of inheritance with reduced penetrance. At least one gene locus on chromosome 7 has been identified. Pigment-dispersion syndrome can be treated with eye drops or other medications. In some cases, laser surgery may be performed.
Also known as: glaucoma-related pigment dispersion syndrome, pigment dispersion syndrome, GPDS1, glaucoma, pigment-dispersion type, glaucoma-RELATED pigment dispersion syndrome, pigment-dispersion syndrome
3 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New laser zaps eye pressure in seconds for glaucoma patients
Disease control Recruiting nowThis study tests a new laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) for people with pigmentary glaucoma, a type of glaucoma that can lead to vision loss. The laser is applied directly through the eye's surface in just a few seconds, aiming to lower high ey…
Sponsor: Mann Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New eye implant could rival standard glaucoma surgery
Disease control Recruiting nowThis study tests whether a tiny drainage device called the Preserflo MicroShunt can lower eye pressure as well as the standard trabeculectomy surgery in adults with open-angle glaucoma. One hundred participants will be randomly assigned to receive one of the two procedures and wi…
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a mild eye zap help restore sight in glaucoma?
Disease control Recruiting nowThis study tests whether a weak electrical current applied to the eye's surface can improve vision in people with open-angle glaucoma. Fifty adults with worsening vision loss will receive either real or sham stimulation over several sessions. The goal is to see if this safe, non-…
Phase: NA • Sponsor: Okuvision GmbH • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC